IDEAS home Printed from https://ideas.repec.org/a/plo/pmed00/0020141.html
   My bibliography  Save this article

A Systematic Review of the Prevalence of Schizophrenia

Author

Listed:
  • Sukanta Saha
  • David Chant
  • Joy Welham
  • John McGrath

Abstract

Background: Understanding the prevalence of schizophrenia has important implications for both health service planning and risk factor epidemiology. The aims of this review are to systematically identify and collate studies describing the prevalence of schizophrenia, to summarize the findings of these studies, and to explore selected factors that may influence prevalence estimates. Methods and Findings: Studies with original data related to the prevalence of schizophrenia (published 1965–2002) were identified via searching electronic databases, reviewing citations, and writing to authors. These studies were divided into “core” studies, “migrant” studies, and studies based on “other special groups.” Between- and within-study filters were applied in order to identify discrete prevalence estimates. Cumulative plots of prevalence estimates were made and the distributions described when the underlying estimates were sorted according to prevalence type (point, period, lifetime, and lifetime morbid risk). Based on combined prevalence estimates, the influence of selected key variables was examined (sex, urbanicity, migrant status, country economic index, and study quality). Conclusions: There is a wealth of data about the prevalence of schizophrenia. These gradients, and the variability found in prevalence estimate distributions, can provide direction for future hypothesis-driven research. Analysis of 188 studies published between 1965 to 2002 yields no difference between men and women and suggests that current text-book estimates for lifetime morbid risk are too high. Background.: Schizophrenia is a very serious mental illness and a major contributor to the global burden of disease. The topic of this study is the question of how common schizophrenia is among different groups and in different countries around the world. “Prevalence” means the number of people who have the disease at a particular time. The study itself is a so-called systematic review, which means the researchers used prespecified methods for finding individual studies and for extracting and summarizing the data from these individual studies in as objective a way as possible. Why Was This Study Done?: Health care planning is based on prevalence estimates, and as a result, many studies on schizophrenia prevalence have been done by researchers around the world. The authors decided to do a systematic review of these studies to come up with a scientifically sound view of the big picture. What Did the Researchers Do?: They looked at a total of 1,721 estimates of the prevalence of schizophrenia from 188 studies and covering 46 countries. They then calculated median prevalence estimates (that is, the middle value of all estimates) over a variety of time periods (see below). What Did They Find?: The take-home message from their study is that about seven to eight individuals out of 1,000 will be affected by schizophrenia. To be more precise, the researchers found the following median estimates for the prevalence of schizophrenia: 4.6 out of 1,000 people have the disease at a specific time point; 3.3 per 1,000 have the disease within a surveillance period one to 12 months long; the lifetime prevalence (the number of people in the population who have ever manifested the disease) is 4.0 per 1,000; and the lifetime morbid risk (the likelihood that a particular individual will develop schizophrenia in their lifetime) is 7.2 per 1,000. While previous research has shown that men have a higher risk of developing schizophrenia, the researchers found that the prevalence of schizophrenia was the same in men and women (suggesting that the course of the illness differs between the sexes). The prevalence of schizophrenia was lower in poorer countries than in richer countries. What Does This Mean?: Based on these estimates, our textbook numbers on lifetime prevalence and overall risk for an individual to develop schizophrenia are probably too high. Taken together with estimates on the incidence of schizophrenia (that is, the annual number of new cases), it is also clear that current treatments fail to cure most patients with schizophrenia. More Information Online.: Additional information on schizophrenia can be found at the following sources.

Suggested Citation

  • Sukanta Saha & David Chant & Joy Welham & John McGrath, 2005. "A Systematic Review of the Prevalence of Schizophrenia," PLOS Medicine, Public Library of Science, vol. 2(5), pages 1-1, May.
  • Handle: RePEc:plo:pmed00:0020141
    DOI: 10.1371/journal.pmed.0020141
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020141
    Download Restriction: no

    File URL: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0020141&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pmed.0020141?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Marziyeh Khoshgoftar & Anahita Khodabakhshi-Koolaee & Mohammad Reza Sheikhi, 2022. "Analysis of the early mother-child relationship in schizophrenic patients," International Journal of Social Psychiatry, , vol. 68(3), pages 548-554, May.
    2. Panayiotis D Ziakas & Rachana Thapa & Louis B Rice & Eleftherios Mylonakis, 2013. "Trends and Significance of VRE Colonization in the ICU: A Meta-Analysis of Published Studies," PLOS ONE, Public Library of Science, vol. 8(9), pages 1-1, September.
    3. Claire Lin & Xiaoyu Zhang & Huajie Jin, 2023. "The Societal Cost of Schizophrenia: An Updated Systematic Review of Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 41(2), pages 139-153, February.
    4. Nadja Razavi & Kay Jann & Thomas Koenig & Mara Kottlow & Martinus Hauf & Werner Strik & Thomas Dierks, 2013. "Shifted Coupling of EEG Driving Frequencies and fMRI Resting State Networks in Schizophrenia Spectrum Disorders," PLOS ONE, Public Library of Science, vol. 8(10), pages 1-11, October.
    5. Emma Facer-Irwin & Nigel J Blackwood & Annie Bird & Hannah Dickson & Daniel McGlade & Filipa Alves-Costa & Deirdre MacManus, 2019. "PTSD in prison settings: A systematic review and meta-analysis of comorbid mental disorders and problematic behaviours," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-28, September.
    6. Vandad Sharifi & Ali Sajjadifar & Homayoun Amini, 2008. "Psychotic-Like Ideations Among a Group of Young Normal Subjects in Iran," International Journal of Social Psychiatry, , vol. 54(5), pages 390-394, September.
    7. Grzegorz Witkowski & Piotr Januszko & Michał Skalski & Anna Mach & Zbigniew Maciej Wawrzyniak & Ewa Poleszak & Bogdan Ciszek & Maria Radziwoń-Zaleska, 2023. "Factors Contributing to Risk of Persistence of Positive and Negative Symptoms in Schizophrenia during Hospitalization," IJERPH, MDPI, vol. 20(5), pages 1-13, March.
    8. Ling Wang & Xi-Wang Fan & Xu-Dong Zhao & Bing-Gen Zhu & Hong-Yun Qin, 2020. "Correlation Analysis of the Quality of Family Functioning and Subjective Quality of Life in Rehabilitation Patients Living with Schizophrenia in the Community," IJERPH, MDPI, vol. 17(7), pages 1-9, April.
    9. Kayla A Chase & Benjamin Feiner & Marcia J Ramaker & Edward Hu & Cherise Rosen & Rajiv P Sharma, 2019. "Examining the effects of the histone methyltransferase inhibitor BIX-01294 on histone modifications and gene expression in both a clinical population and mouse models," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-17, June.
    10. Ó Gráda, Cormac & Lee, Chihua & Lumey, L. H., 2023. "How Much Schizophrenia Do Famines Cause?," MPRA Paper 119448, University Library of Munich, Germany.
    11. Gianluca Ursini & Pasquale Di Carlo & Sreya Mukherjee & Qiang Chen & Shizhong Han & Jiyoung Kim & Maya Deyssenroth & Carmen J. Marsit & Jia Chen & Ke Hao & Giovanna Punzi & Daniel R. Weinberger, 2023. "Prioritization of potential causative genes for schizophrenia in placenta," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    12. Ming Li & Hui Zhang & Xiong-jian Luo & Lei Gao & Xue-bin Qi & Pierre-Antoine Gourraud & Bing Su, 2013. "Meta-Analysis Indicates That the European GWAS-Identified Risk SNP rs1344706 within ZNF804A Is Not Associated with Schizophrenia in Han Chinese Population," PLOS ONE, Public Library of Science, vol. 8(6), pages 1-8, June.
    13. Nathan T. Pearson & James H. Berry, 2019. "Cannabis and Psychosis Through the Lens of DSM-5," IJERPH, MDPI, vol. 16(21), pages 1-14, October.
    14. Ary Gadelha & Vanessa Kiyomi Ota & Jose Paya Cano & Maria Isabel Melaragno & Marilia A C Smith & Jair de Jesus Mari & Rodrigo A Bressan & Sintia Iole Belangero & Gerome Breen, 2012. "Linkage Replication for Chromosomal Region 13q32 in Schizophrenia: Evidence from a Brazilian Pilot Study on Early Onset Schizophrenia Families," PLOS ONE, Public Library of Science, vol. 7(12), pages 1-6, December.
    15. Huichen Gao & Shijuan Wang, 2022. "The Intellectual Structure of Research on Rural-to-Urban Migrants: A Bibliometric Analysis," IJERPH, MDPI, vol. 19(15), pages 1-19, August.
    16. Wessel A. C. Burger & Vi Pham & Ziva Vuckovic & Alexander S. Powers & Jesse I. Mobbs & Yianni Laloudakis & Alisa Glukhova & Denise Wootten & Andrew B. Tobin & Patrick M. Sexton & Steven M. Paul & Chri, 2023. "Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    17. Song, Shige & Wang, Wei & Hu, Peifeng, 2009. "Famine, death, and madness: Schizophrenia in early adulthood after prenatal exposure to the Chinese Great Leap Forward Famine," Social Science & Medicine, Elsevier, vol. 68(7), pages 1315-1321, April.
    18. Jiahui Ma & Lailai Yan & Tongjun Guo & Siyu Yang & Chen Guo & Yaqiong Liu & Qing Xie & Jingyu Wang, 2019. "Association of Typical Toxic Heavy Metals with Schizophrenia," IJERPH, MDPI, vol. 16(21), pages 1-12, October.
    19. Angelo Barbato & Martine Vallarino & Filippo Rapisarda & Antonio Lora & Alberto Parabiaghi & Barbara D’Avanzo & Alain Lesage, 2016. "Do people with bipolar disorders have access to psychosocial treatments? A survey in Italy," International Journal of Social Psychiatry, , vol. 62(4), pages 334-344, June.
    20. Valeria Latorre & Antonio Messeni Petruzzelli & Antonio Emmanuele Uva & Carlo Ranaudo & Domenico Semisa, 2022. "Unveiling the actual cost of Schizophrenia: An Activity‐Based Costing (ABC) approach," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(3), pages 1366-1380, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pmed00:0020141. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosmedicine (email available below). General contact details of provider: https://journals.plos.org/plosmedicine/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.